IT1264530B - Impiego dei polisaccaridi nelle neuropatie atrofico degenerative - Google Patents

Impiego dei polisaccaridi nelle neuropatie atrofico degenerative

Info

Publication number
IT1264530B
IT1264530B ITMI921881A ITMI921881A IT1264530B IT 1264530 B IT1264530 B IT 1264530B IT MI921881 A ITMI921881 A IT MI921881A IT MI921881 A ITMI921881 A IT MI921881A IT 1264530 B IT1264530 B IT 1264530B
Authority
IT
Italy
Prior art keywords
atrophic
polysaccharides
neuropathies
degenerative neuropathies
degenerative
Prior art date
Application number
ITMI921881A
Other languages
English (en)
Inventor
Giuseppe Prino
Ennio Lanzarotti
Benito Casu
Laura Ferro
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Priority to ITMI921881A priority Critical patent/IT1264530B/it
Publication of ITMI921881A0 publication Critical patent/ITMI921881A0/it
Priority to CA002100197A priority patent/CA2100197A1/en
Priority to EP93202089A priority patent/EP0582330A1/en
Priority to US08/094,626 priority patent/US5605891A/en
Priority to JP19149093A priority patent/JP3264560B2/ja
Publication of ITMI921881A1 publication Critical patent/ITMI921881A1/it
Application granted granted Critical
Publication of IT1264530B publication Critical patent/IT1264530B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

I polisaccaridi, ed in particolare i sulfomucopolisaccaridi, loro miscele, frazioni e derivati sono agenti attivi nella terapia delle neuropatie atrofico degenerative, in particolare delle neuropatie periferiche.
ITMI921881A 1992-07-31 1992-07-31 Impiego dei polisaccaridi nelle neuropatie atrofico degenerative IT1264530B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI921881A IT1264530B (it) 1992-07-31 1992-07-31 Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
CA002100197A CA2100197A1 (en) 1992-07-31 1993-07-09 Use of polysaccharides in acute peripheral neuropathies
EP93202089A EP0582330A1 (en) 1992-07-31 1993-07-16 Use of polysaccharides for treating acute peripheral neuropathies
US08/094,626 US5605891A (en) 1992-07-31 1993-07-21 Use of polysaccharides in acute peripheral neuropathies
JP19149093A JP3264560B2 (ja) 1992-07-31 1993-08-02 急性末梢神経障害治療用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921881A IT1264530B (it) 1992-07-31 1992-07-31 Impiego dei polisaccaridi nelle neuropatie atrofico degenerative

Publications (3)

Publication Number Publication Date
ITMI921881A0 ITMI921881A0 (it) 1992-07-31
ITMI921881A1 ITMI921881A1 (it) 1994-01-31
IT1264530B true IT1264530B (it) 1996-10-02

Family

ID=11363799

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921881A IT1264530B (it) 1992-07-31 1992-07-31 Impiego dei polisaccaridi nelle neuropatie atrofico degenerative

Country Status (5)

Country Link
US (1) US5605891A (it)
EP (1) EP0582330A1 (it)
JP (1) JP3264560B2 (it)
CA (1) CA2100197A1 (it)
IT (1) IT1264530B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6573251B2 (en) * 1994-03-30 2003-06-03 Denis Barritault Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate
IT1271685B (it) * 1994-08-03 1997-06-04 Crinos Industria Farmaco Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche
FR2763848B1 (fr) * 1997-05-28 2000-01-28 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
US6498246B1 (en) * 1998-02-26 2002-12-24 Seikagaku Corporation Glycosaminoglycan derivatives and processes for preparing same
RU2129871C1 (ru) * 1998-09-17 1999-05-10 Ларионов Евгений Викторович Способ получения гликозаминогликанов
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
MXPA02000142A (es) * 1999-06-30 2003-07-21 Hamilton Civic Hospitals Res Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
BR0113886A (pt) * 2000-09-08 2003-07-15 Hamilton Civic Hospitals Res Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit
JP4732604B2 (ja) * 2001-03-07 2011-07-27 生化学工業株式会社 増殖因子活性増強剤
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
JP4576583B2 (ja) * 2005-03-22 2010-11-10 キユーピー株式会社 ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物
DE102005017799A1 (de) * 2005-04-18 2006-10-19 Abbott Gmbh & Co. Kg Verwendung von Heparin und Heparinderivaten zur Modulation des Neuritenwachstum-kontrollierenden Nogo-Rezeptors
ITPD20050168A1 (it) 2005-06-01 2006-12-02 Fidia Advanced Biopolymers Srl Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
EP1992645A4 (en) * 2006-02-24 2011-03-09 Q P Corp NOVEL HYALURONIC ACID WITH LOW MOLECULAR WEIGHT AND / OR SALT THEREOF, AND COSMETIC PREPARATION, PHARMACEUTICAL COMPOSITION AND EACH FOOD COMPOSITION USING THE SAME
US8752724B2 (en) * 2007-04-16 2014-06-17 Bobrick Washroom Equipment, Inc. Insert for a container
GB0714500D0 (en) * 2007-07-25 2007-09-05 Hunter Fleming Ltd composition and treatment
BR112016029008B1 (pt) 2014-06-12 2023-05-02 Tx Medic Ab Uso de sulfato de dextrana com peso molecular médio abaixo de 10000 da para induzir a angiogênese em um sujeito

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620906A (it) *
DE3405240A1 (de) * 1984-02-15 1985-08-22 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Rheuma- und venenmittel
US5356895A (en) * 1984-03-19 1994-10-18 The Rockefeller University 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins
US5187089A (en) * 1990-06-21 1993-02-16 Incyte Pharmaceuticals, Inc. Protease nexin-i variants which inhibit elastase
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Also Published As

Publication number Publication date
EP0582330A1 (en) 1994-02-09
US5605891A (en) 1997-02-25
ITMI921881A0 (it) 1992-07-31
JPH06157322A (ja) 1994-06-03
ITMI921881A1 (it) 1994-01-31
CA2100197A1 (en) 1994-02-01
JP3264560B2 (ja) 2002-03-11

Similar Documents

Publication Publication Date Title
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
MY106272A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants.
NO934706L (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
PT902789E (pt) Derivados de androsteno
IT8125722A0 (it) Derivati amminoalchil-eterociclici, loro procedimento di preparazione eloro applicazione in terapia.
IT8124835A0 (it) Nuovi derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia.
ES2137372T3 (es) Solucion antifungica para las uñas.
IT1209603B (it) Derivati 2,6-disostituiti di naftalene, procedimento per prepararli e loro uso nel campo farmaceutico e cosmetico.
NO954878L (no) Pyrrolderivater
MXPA02004701A (es) Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
NO890046L (no) Disubstituerte pyridiner.
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti &#34;scavengers&#34; di radicali liberi dell&#39;ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DK0391185T3 (da) 1,8-Naphthyridiner
IT8323925A0 (it) Derivati bezilidenici solforati, loro preparazione e loro applicazione in terapia.
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
AR026756A1 (es) Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos
RU94039553A (ru) Средство для лечения хронического простатита
NO901076D0 (no) Substituerte bifenyler.
IT1216556B (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730